| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/03/2008 | WO2008001929A1 Treatment agent for inflammatory bowel disease |
| 01/03/2008 | WO2008001770A1 Antiallergic composition and agent, and food, beverage and animal feed each containing the composition or agent |
| 01/03/2008 | WO2008001769A1 Intestinal immunity-activating substance or agent, and food, beverage and animal feed containing the same |
| 01/03/2008 | WO2008001498A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 01/03/2008 | WO2008001491A1 Antiallergic agent |
| 01/03/2008 | WO2008000968A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000967A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | WO2008000777A2 Phenyl- pyrazole derivatives, process for their preparation and their pharmaceutical use |
| 01/03/2008 | WO2008000421A2 Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors |
| 01/03/2008 | WO2008000419A1 S1p receptor modulators for treating multiple sclerosis |
| 01/03/2008 | WO2007128564A3 Use of a compound with rankl activity |
| 01/03/2008 | WO2006113942A3 Method of inhibiting cathepsin activity |
| 01/03/2008 | US20080004347 serotonin (5-HT2C) receptor antagonist; antidepressant, anxiolytic agent; seasonal affective disorders, sleep disorders, cardiovascular pathologies, pathologies of the digestive system, insomnia and fatigue resulting from jetlag, appetite disorders and obesity |
| 01/03/2008 | US20080004344 Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use |
| 01/03/2008 | US20080004297 Compounds and therapeutical use thereof |
| 01/03/2008 | US20080004295 Novel compounds |
| 01/03/2008 | US20080004277 Triazole compounds that modulate HSP90 activity |
| 01/03/2008 | US20080004273 Inhibitors of VEGF and HGF receptor signaling; treating cell proliferative diseases; N-(4-(6,7-Dimethoxyquinolin-4-yloxy)-3-fluorophenyl)-2-oxo-1-phenylpyrrolidine-3-carboxamide |
| 01/03/2008 | US20080004270 3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors |
| 01/03/2008 | US20080004257 Kinase inhibitors |
| 01/03/2008 | US20080004212 Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin |
| 01/03/2008 | US20080004209 Incubating resistin with a cathepsin, in the presence of a test compound; and measuring the level of proteolyzed resistin |
| 01/03/2008 | US20080003294 Methods for pulmonary delivery of interleukin-2 |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 01/03/2008 | US20080003235 Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof |
| 01/03/2008 | US20080003233 Recombinant Vaccines Against Caligid Copepods (Sea Lice) and Antigen Sequences Thereof |
| 01/03/2008 | US20080003229 the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; vaccine |
| 01/03/2008 | US20080003228 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
| 01/03/2008 | US20080003218 Anti-IgE antibodies |
| 01/03/2008 | US20080003209 Method for treatment of neurodegenerative diseases and the effects of aging |
| 01/03/2008 | US20080003201 Interleukin-12 as a veterinary vaccine adjuvant |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2655999A1 Treating agent of inflammatory bowel disease |
| 01/03/2008 | CA2655568A1 Organic compounds |
| 01/03/2008 | CA2653728A1 Delta-tocotrienol treatment and prevention of pancreatic cancer |
| 01/03/2008 | CA2653569A1 S1p receptor modulators for treating multiple sclerosis |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1873147A1 Phthalazinone derivative and pharmaceutical comprising the same |
| 01/02/2008 | EP1873140A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | EP1873139A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 01/02/2008 | EP1872787A1 Use of defibrotide for the inhibition of heparanase |
| 01/02/2008 | EP1872786A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 01/02/2008 | EP1871414A1 Method for traeting inflammatory bowel disease (ibd) by an anti-cd20 antibody |
| 01/02/2008 | EP1871413A2 Minor allergen control to increase safety of immunotherapy |
| 01/02/2008 | EP1871412A2 Soluble vox2 protein as immunoregulatory factor |
| 01/02/2008 | EP1871350A1 Methods of increasing natural killer cell activity for therapy |
| 01/02/2008 | EP1548027B1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 01/02/2008 | EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 01/02/2008 | EP1435986B1 Igf-binding protein-derived peptide |
| 01/02/2008 | EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor |
| 01/02/2008 | EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 01/02/2008 | EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 01/02/2008 | EP1317476B1 Reagents for cell selection and methods of use |
| 01/02/2008 | EP1272161B1 Lipid-based drug delivery systems against parasitic infections |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1252307B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/02/2008 | EP0988044B1 Water/ethanol centipeda cunninghamii plant extract |
| 01/02/2008 | EP0830139B1 Modified myelin protein molecules |
| 01/02/2008 | EP0610335B1 Methods for designing recombitope peptides |
| 01/02/2008 | CN101098958A Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 01/02/2008 | CN101098957A Method of producing lactic acid bacterium having antiallergic effect |
| 01/02/2008 | CN101098894A High-molecular fucoidan, method of producing the same and cosmetic composition |
| 01/02/2008 | CN101098892A Antibodies against IL-13 receptor alpha 1 and uses thereof |
| 01/02/2008 | CN101096386A Dectin-1 and heat shock protein Hsp60 polymer and coding nucleic acid and application thereof |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095885A Chinese traditional medicine for treating myocarditis |
| 01/02/2008 | CN101095872A Chinese traditional medicine composition for treating anaphylactoid purpura nephritis |
| 01/02/2008 | CN101095856A Chinese traditional medicine for treating anaphylactoid purpura nephritis |
| 01/02/2008 | CN101095855A Chinese traditional medicine preparations for treating anaphylactoid purpura nephritis |
| 01/02/2008 | CN101095854A Chinese traditional medicine for treating anaphylactoid purpura nephritis |
| 01/02/2008 | CN101095721A Sea cucumber Chinese medicinal herb preparations for preventing diseases and increasing the weight |
| 01/02/2008 | CN101095717A Agent for improving body immune function |
| 01/02/2008 | CN101095716A Use of cortex eucommiae total polyoses in the preparing of the medicine for preventing and treating systematic lupus erythematosus |
| 01/02/2008 | CN101095708A Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating systematic lupus erythematosus |
| 01/02/2008 | CN101095702A Graininess medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
| 01/02/2008 | CN101095701A Flaky medicine containing hirsutella.hepia - cordycepsíífungusíípowder and method for preparing the same |
| 01/02/2008 | CN101095686A Method for producing lecithin capsule, lin ester alcohols and lecithin oral liquid |
| 01/02/2008 | CN101095671A Iguratimod oral double-layer sustained-release preparation |
| 01/02/2008 | CN101095465A Application of low-polyxylose complicated preparation in the preparing of feedstuff that is capable of enhancing immunity of marine animals |
| 01/02/2008 | CN101095462A Method for synthesizing the feed additive - isoflavone |
| 01/02/2008 | CN101095447A Health-care coffee having waste-discharging and youth-keeping function and the preparing method thereof |
| 01/02/2008 | CN100359004C Natural killer cell for transgenic expression cell chemotactic factors |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358893C Use of and some novel imidazopyridines |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358891C Pyranones useful as ATM inhibitors |
| 01/02/2008 | CN100358869C Carbamate caspase inhibitors and uses thereof |
| 01/02/2008 | CN100358861C Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358542C Medicine capable of reducing blood fat and treating anaphylactic rhinitis and preparation method thereof |
| 01/02/2008 | CN100358535C Composition of mycobacterium polysaccharide and its preparation |
| 01/02/2008 | CN100358528C Use of mometasone furoate for treating airway passage and lung diseases |
| 01/02/2008 | CN100358514C Remedies for allergic eye diseases |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |